St. Jude Medical

The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.

August 6

FDA cites increased risk from heart pumps made by St. Jude acquisition target

Thoratec’s heart pump has had trouble with blood clots.
July 25
The deal announcement came as St. Jude reported a decline in quarterly earnings Wednesday, but it beat earnings forecasts.

St. Jude sees good outlook for Thoratec HeartMate 3

St. Jude Medical is banking on a positive forecast after the company announced plans last week to buy Thoratec Corp. in a $3.4 billion deal that would be St. Jude’s biggest corporate acquisition ever.
July 22

St. Jude Medical to buy Calif. heart-device firm for $3.4B

Little Canada medical device maker St. Jude Medical announced a definitive agreement Wednesday to acquire California heart-device firm Thoratec for $3.4 billion. The deal, the largest ever for St. Jude, is expected to close by the end of the year.
July 21

St. Jude Medical reportedly in talks for California heart device company

Minnesota firm reportedly negotiating a $3 billion purchase of Thoratec Corp.
July 10

Devicemakers from Minnesota paid hospitals, docs $211M in 2014

National data show state firms’ payments to doctors and hospitals.
June 4

New St. Jude device treats chronic pain using iPod

Bluetooth technology allows patients to control treatment.
May 23

St. Jude facing safety questions regarding tiny new pacemaker

Physicians, and some stock analysts, are closely watching the safety profile of tiny novel pacemakers like the Nano­stim in ongoing studies. Implants of the device have been halted in Europe after several became dislodged.
April 20

St. Jude to buy chronic pain treatment company for $215 million

Device from Spinal Modulation, of Belgium, stimulates nerve center to treat chronic pain.
April 15

Medtronic gets European approval for smallest pacemaker

Medtronic joins crosstown rival St. Jude Medical Inc. in speeding toward full commercial approval from the Food and Drug Administration for U.S. sales.
March 28

St. Jude launches trial of heart valve for children

Responding to calls for pediatric devices, St. Jude launches clinical trial of a mechanical heart valve for children.
March 26

CEO Pay Watch: Daniel Starks, St. Jude Medical

CEO Pay Watch St. Jude Medical Inc. Daniel Starks, chairman, president, CEO Total compensation: $6,823,764 for the year ended Dec. 31 Salary: $1,097,574 Non-equity…
March 23

St. Jude Medical stock weathers a downgrade amid concern over growth

It has been on a steady rise since its fall amid a Wells Fargo downgrade, growth concerns.
March 20

Minnesota heart device makers tout approvals, advances

Local companies tout approvals, products, outcomes in time for cardiologists’ annual meeting.
March 16

A high-stakes heart-valve race

Boston Scientific, Medtronic and St. Jude are in the competition over a medical technology niche poised to balloon to $4 billion in global sales five years from now.
March 13
Nurse Jillian Schoenleben held a valve fashioned from a cow's, and par...

Risks, benefits weighed in JAMA study on valve replacement

Study found that 1 in 4 died within a year but many were aged and ill with other ailments.
March 12

St. Jude Medical looks to restart clinical trial for valve device

The valve device is seen as a promising niche for medical technology.
February 27
Gina Jacobsen, RN, checked on patient Joe Jones after Fouad Bachour, M...

St. Jude device gives early warning on heart failure

A new device made by St. Jude Medical detects subtle changes in blood pressure, allowing doctors to treat failing hearts before patients end up in the emergency room.
February 26

St. Jude Medical to pay $14.25 million in Riata lawsuits

The firm agreed to settle claims for the defibrillator leads, which degraded in as little as four years.
February 20

Medical device surveillance on the horizon

Tracking medical devices could eventually spare patients from suffering complications.
January 28

St. Jude Medical earnings meet expectations

The company plans to adopt a currency-hedging program to moderate earnings fluctuations caused by exchange rates.
January 14

St. Jude Medical says it will meet earnings expectations

The company also said it will begin a $500 million stock buyback program.
December 22, 2014

Medtronic, St. Jude roll out enhanced devices to restore normal heart rhythms

Medtronic, St. Jude got OK on latest systems offering more options to resynchronize.
November 20, 2014

In era of growing risk, emphasis grows on medical device data

At a conference in Minneapolis, medical insurers had a message for devicemakers: Let’s see the numbers.
November 15, 2014
Rep. Eric Paulsen

Schafer: Killing tax on devices won't bring back jobs

One of the most reviled taxes in recent memory, the medical device excise tax, seems to be near the end of its short life. Enacted…
November 5, 2014

With Republican Senate, many eye a device-tax repeal

Critics say a likely presidential veto means a repeal would come as part of a broader bill.